Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) SHH

7.19

-0.21(-2.84%)

Updated at January 15 03:00PM

Currency In CNY

Valuation

Market Cap6.34B
Enterprise Value7.09B
P/E Ratio-17.11
PEG Ratio1.27
Price/Sales Ratio2.71
Price/Book Ratio4.17
Enterprise/Revenue3.77
Enterprise/EBITDA-33.11

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.16
Operating Margin-0.15

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.24

Income Statement

Revenue1.41B
Revenue/Share2.66
Gross Profit676.44M
EBITDA-159.6M
Net Income-274.46M
Diluted EPS-0.69

Balance Sheet

Total Cash110.74M
Total Cash/Share0.28
Total Debt1.24B
Total Debt/Equity1.8
Current Ratio0.82
Book Value Per Share1.84

Price History

52-Week Change-57.18
52-Week High19.1
52-Week Low7.18
Moving Average 50 Days8.82
Moving Average 200 Days9.61

Statistics

Average Volume5.82M
Shares Outstanding400.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.16
Last Split FactorN/A
Last Split DateN/A